Premenstrual dysphoric disorder (PMDD). A review of the diagnosis, epidemiology, and therapy modes;Pramenstruelle dysphorische storung (PMDS). Ein uberblick uber diagnose, epidemiologie und therapieansatze

Nervenarzt

Volumn 68, Issue 9, 1997, Pages 708-718

  Lenzinger, E ^a   Diamant, K ^a   Vytiska Binstorfer, E ^a   Kasper, S ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antidepressants; Behavioral therapy; Brainstem evoked responses; Diagnostic criteria; Light therapy; PMDD; Sleep deprivation

Indexed keywords

ANTIDEPRESSANT AGENT; LITHIUM; NEFAZODONE; SEROTONIN UPTAKE INHIBITOR;

ANXIETY NEUROSIS; DEPRESSION; DYSPHORIA; FEMALE; HUMAN; PHOTOTHERAPY; PREMENSTRUAL SYNDROME; PSYCHOTHERAPY; REVIEW; SLEEP DEPRIVATION; AUSTRIA; CROSS-SECTIONAL STUDY; DIFFERENTIAL DIAGNOSIS; INCIDENCE; MULTIMODALITY CANCER THERAPY; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; AUSTRIA; COMBINED MODALITY THERAPY; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INCIDENCE; PREMENSTRUAL SYNDROME; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0030879362     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050185     Document Type: Review

References (112)

1. Allen D (1996) Are alcoholic women more likely to drink premenstrually? Alcohol Alcohol 31:145-147
2. Andersch B (1983) Bromocriptine and premenstrual syndroms: a survey of double-blind trials. Obstet Gynecol Surv 38:634
3. Avery DH, Wildschitz G, Rafaelson OJ (1982) Nocturnal temperature in affective disorder. J Affective Disord 4:61-71
4. Bancroft J, Cook A, Williamson L (1988) Food craving, mood and the menstrual cycle. Psychol Med 18:855-860
5. Berger CP, Presser B (1994) Alprazolam in the treatment of two subsamples of patients with late luteal phase dysphoric disorder: a double-blind, placebo-controlled crossover study. Obstet Gynecol 84:379-385
6. Both-Othman B, Rubinov DR, Hoban MC et al. (1988) Menstrual cycle phase-related changes in appetite in patients with premenstrual syndrome and in control subjects. Am J Psychiatry 145:628-631
7. Brandenburg S, Tuynman-Qua H, Verheij R, Pepplinkhuizen (1993) Treatment of premenstrual syndrome with fluoxetine: an open study, Int Clin Psychopharmacol 8:315-317
8. Caan B, Duncan D, Hiatt R, Lewis J, Chapman J, Armstrong MA (1993) Association between alcoholic and cafeinated beverages and premenstrual syndrom. J Reprod Med 38:630-636
9. Christensen AP, Oei TP (1995) The efficacy of cognitive behavior therapy in treating premenstruel dysphoric changes. J Affective Disord 33:57-63
10. Chuong C, Coulani C, Bergstralh E et al. (1988) Clinical trial of naltrexon in premenstrual syndrome. Obstet Gynecol 72:232-236
11. Cullberg J (1972) Mood changes and menstrual symptoms with different gestagen/estrogen combinations. A double-blind comparison with placebo. Acta Psychiat Scand 236:1-86
12. Dalton K, Greene R (1953) The premenstrual syndrome. Br Med J 1:1007
13. DeJong R, Rubinow DR, Roy-Byrne P et al. (1985) Premenstrual mood disorder and psychiatric illness. Am J Psychiatry 142 1359-1361
14. Deicken F (1988) Verapamil in the treatment of PMS: a case report. Biol Psychiatry 24:689-692
15. Deleon-Jones FA, Val E, Hertz C (1982) Lithium in the treatment of PMS. A case report. Am J Psychiatry 139:950-951
16. Dubovsky SL, Franks RD (1983) Intracellular calcium ions in affective disorders. Biol Psychiatry 18:781-797
17. Eriksson E. Lisjo R, Sunblad K et al. (1990) Effect of clomipramine on premenstrual syndrome. Acta Psychiatr Scand 81:87-88
18. Eriksson E, Hedberg MA, Andersch B, Sundblad C (1995) The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology 12:167-176
19. Facchinetti F, Genazzani AD, Martignoni E et al. (1990) Neuroendocrine correlates of premenstrual syndrome. Psychoneuroendocrinology 15:269
20. Farmer G, Isakson TR, Coy DJ, Renner KJ (1996) In vivo evidence for progesteron dependent decreases in serotonin release in the midbrain central grey: relation to the induction of lordosis. Brain Res 711:84-92
21. Fink G, Sumner BE, Rosie R, Grace O, Quinn JP (1990) Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell Mol Neurobiol 16:325-344
22. Fontana AM, Palfai TG (1994) Psychosocial factors in premenstrual dysphoria: stressors, appraisal, and coping processes. J Psychosomat Res 38:557-567
23. Frank R (1931) The hormonal causes of premenstrual tension. Arch Neurol Psychiatry 26:1053
24. Freeman EW, Rickels K, Sondheimer SJ et al (1994) Nefazodone in the treatment of premenstrual syndrome: a preliminary study. J Clin Psychopharmacology 14:180-186
25. Freeman EW, Schweizer E, Rickels K (1995) Personality factors in women with premenstrual syndrome. Psychosom Med 57:453-459
26. Freinhar JP (1984) Alprazolam and premenstrual syndrome. J Clin Psychiatry 45:526
27. Friedman D, Jaffe A (1985) Influence of lifestyle on the premenstrual syndrome. J Reprod Med 30:715-719
28. Futterman LA, Jones JE, Miccio-Fonseca LC (1992) Severity of premenstrual symptoms in relation to medical/psychiatric problems and life experiences.
29. Gallant SJ, Popiel DA, Huffman DM, Chakraborty PK, Hamilton JA (1992) Using daily ratings to confirm premenstrual syndrome/late luteal phase dysphoric disorder. Part I. Effects of demand characteristics and expectations. Psychosom Med 54:149-166 part II. What makes a "real" difference? Pyschosom Med 54:167-168
30. Gallant SJ, Popiel DA, Huffman DM, Chakraborty PK, Hamilton JA (1992) Using daily ratings to confirm premenstrual syndrome/late luteal phase dysphoric disorder. Part I. Effects of demand characteristics and expectations. Psychosom Med 54:149-166 part II. What makes a "real" difference? Pyschosom Med 54:167-168
31. Giannini AJ, Sullivan B, Sarachene J (1988) Clonidine in the treatment of premenstrual syndrome: a subgroup study. J Clin Psychiatry 49:62-63
32. Gonsalves L, Domb J, Gidwani G (1992) Depression, chronic fatigue and the premenstrual syndrome. Prim Care 18:369-380
33. Gray TK, McAdoo T, Hartley L et al. (1982) Fluctuation of serum concentration of 1,25-dihydroxyvitamin D3 during the menstrual cycle. Am J Obstet Gynecol 14:880-884
34. Hall RCW (1983) Psychiatric effects of thyroid dysfunction. Psychosomatics 24:7
35. Halbreich U, Endicott J (1981) Possible involvement of endorphine withdrawal or imbalance in specific premenstrual syndromes and poatpartum depression. Med Hypotheses 7:1045
36. Halbreich U, Endicott J, Schacht S et al. (1982) The diversity of premenstrual changes as reflected in the premenstruell assessment form. Acta Psychiat Scand 65:46-65
37. Hargrove JT, Abraham GE (1982) The incidence of prmenstrual tension in a gynecological clinic J Reprod Med 2:721-724
38. Harrer G, Schulz V (1993) Zur Prüfung der antidepressiven Wirksamkeit von Hypericum. Nervenheilkunde 12:271-273
39. Harrison WM, Endicott J, Nee J (1989) Treatment of premenstrual depression with nortryptylin: a pilot study. J Clin Psychiatry 50:136-139
40. Harrison WM, Endicott J, Nee J (1990) Treatment of premenstrual dysphoria with alp razolam. A controlled study. Arch Gen Psychiatry 47:270-275
41. Howard R, Mason P, Taghavi E, Spears G (1992) Brainstem auditory evoked responses (BAERs) during the menstrual cycle in women with and without premenstrual syndrome. Biol Psychiatry 32:682-690
42. Hurt SW, Schnurr PP, Severino SK, Freeman EW, Gise LH (1992) Late luteal phase dysphoric disorder in 670 women evaluated for premenstrual complaints. Am J Psychiatry 149:225-230
43. Kasper S, Sack DA, WehrTA (1989) Therapeutischer Schlafentzug und Energiehaushalt. In: Pflug B, Lemmer B (Hrsg) Chronobiologie und Chronopharmakologie. Antidepressiva-Schlafentzug-Licht. Fischer, Stuttgart New York, S 53-79
44. Kasper S, Stamenkovic M, Fischer G (1995) Recurrent brief depression: diagnosis, epidemiology and potential pharmacological options. CNS Drugs 4:222-229
45. Katz FH, Romth P (1972) Plasma aldosterone and renin activity during the menstrual cycle. J Clin Endocrinol 34:819-822
46. Kendall KE, Schnurr PP (1987) Vitamine B and PMS. Obstet Gynecol 70:145-149
47. Keye WR, Hammond DC, Strong T (1986) Medical and psychological characteristics of women presenting with premenstrual symptoms. Obstet Gynecol 68:634-637
48. Kerr GD, Day JB, Monday MR et al. (1980) Dydrogesterone in the treatment of the premenstrual syndrome. Practitioner 224:852-855
49. Kuhs H, Tolle R (1991) Sleep deprivation therapy. Biol Psychiatry 29:1129-1148
50. Labrum AH (1983) Hypothalamic, pineal and pituitary factors in the premenstrual syndrom. J Reprod Med 438-445
51. Lapierre YD, Ravindran A, Bialik D (1993) Dysthymia and serotonin Int J Psychopharmacology 8[Suppl 2]:87-90
52. Lindner H, Kirkby RJ (1992) Premenstrual symptoms: the role of irrational thinking. Psychol Rep 71:247-252
53. Lipman KM (1992) Nocturnal temperature in LLPOD. Am J Psychiatry 149:850-851
54. Logue CM, Moos RF (1986) Perimental symptoms: prevalence and risk factors. Psychosom Med 48:388-414
55. London RS, Sundaram S, Manimekalat S et al. (1984) The effect of alphatocopherol on premenstrual symptomatology: a double-blind study. J Am Coll Nutr 3:351
56. Mauri M, Reid RL, MacLean AW (1988) Sleep in the premenstrual phase: a self report study of PMS patients and normal controls. Acta Psychiat Scand 78:82-86
57. McMillan MJ, Pihl RO (1987) Premenstrual depression: a distinct entity. J Abnorm Psychol 96:149-154
58. Messinis E, Lolis D (1988) Treatment of premenstrzal mastalgia with tamoxifen. Acta Obstet Gynaecol Scand 67:307-309
59. Montgomery SA, Montgomery D, Baldwin D et al. (1990) The duration, nature and recurrence rate of brief depression. Prog Neuro Psychopharmacol Piol Psychiatry 14:729-735
60. Moos RH (1969) The development of a menstrual distress questionnaire. Psychosom Med 30:853-867
61. Morris NM, Udry JR (1972) Contraceptive pills and day-by-day feelings of well-being. Am J Obstet Gynecol 113:763-765
62. Morse CA, Dennerstein L, Varnavides K et al. (1988) Menstrual cycle symptoms: comparison of a non-clinical sample with a patient group. J Affective Disord 14:41-50
63. Mortola JF (1994) A risk-benefit appraisal of drugs in the management of premenstrual syndrome. Drug Saf 10:160-169
64. Muse KN, Cetel NS, Futterman LA (1984) The premenstrual syndrome. Effects of "medical ovariectomy". N Engl J Med 311:1345
65. Nikolai TF, Mulligan GM, Gribble RK (1990) Thyroid function and treatment in premenstrual syndrome. J Clin Endocrinol Metab 70:1108
66. Neumeister A, Praschak-Rieder N, Hesselmann B et al. (1995) Effects of tryptophan depletion in patients with seasonal affective disorder during a stable response to light therapy. (in press)
67. Noda Y, McGreer PL, McGreer EG (1982) Vitamine E and the modulation of neurotransmitters. Neurobiol Aging 3:173
68. O'Brien PMS, Symonds EM (1982) Prolactin levels in the premenstrual syndrome. J Obstet Gynaecol 89:306
69. Parlee MB (1982) Changes in moods and activation levels during the menstrual cycle in experimentally naive subjects. Pschol Women Q7:119-151
70. Parry BL, Wehr TA (1987) Therapeutic effect of sleep deprivation in patients with premenstrual syndrome. Am J Psychiatry 144:808-810
71. Parry BL, Mahan AM, Mostoffi N, Klauber MR, Lew GS, Gillin JC (1993) Light therapy of late luteal phase dysphoric disorder: an extended study. Am J Psychiatry 150:1417-1419
72. Parry BL, Cover H, Mostofi N et al. (1995) Early vs. late partial sleep deprivation in premenstrual dysphoric disorder and normal comparison subjects. Am J Psychiatry 152:404-412
73. Pearlstein TB, Stone AB (1994) Long-term fluoxetine treatment of late luteal phase dysphoric disorder. J Clin Psychiatry 55:332-335
74. Price WA, Giannini AJ (1984) The use of clonidine in pemenstrual tension syndrome. J Clin Pharmacol 24:463-465
75. Rapkin AJ, Edelmuth E, Chang LC et al. (1987) Whole-blood serotonin in premenstrual syndrome. Obstet Gynecol 70:533-537
76. Rapkin AJ, Chang LC, Reading AE (1989) Tryptophan loading test in premenstrual syndrome. J Obstet Gynecol 10:140-144
77. Rausch JL, Janowsky DS (1982) Premenstrual tension: etiology. In: Friedman RC (ed) Behavior and the menstrual cycle. Dekker, New York, pp 397-427
78. Rausch JL, Janowsky DS, Golshan S et al (1988) Atenolol treatment of late luteal phase dysphoric disorder. J Affective Disord 15:141-147
79. Rickeis K, Freeman E, Sondheimer S (1989) Buspirone in treatment of premenstrual syndrome. Lancet 1:777
80. Rivera-Tovar AD, Frank E (1990) Late luteal phase dyshoric disorder in young women. Am J Psychiatry 147:1634-1636
81. Rodin M (1992) The social construction of premenstrual syndrome. Soc Sci Med 35:49-56
82. Roy-Byrne PP, Rubinow DR, Hoban MC et al. (1987) TSH and prolactin responses to TRH in patients with premenstrual syndrome. Am J Psychiatry 44:480
83. Sampson GA, Heathcote PR, Wordsworth J et al. (1988) Premenstrual syndrome:a double blind cross-over study of treatment with dydrogesterone and placebo. Br J Psychiatry 153:232-235
84. Schnurr PP (1988) Some correlates of prospectively defined premenstrual syndrome. Am J Psychiatry 145:491-494
85. Severino SK, Wagner DR, Moline ML, Hurt SW, Pollak CP, Zendell S (1991) High body temperature in premenstruel syndrome and late luteal phase dysphoric disorder. Am J Psychiatry 148:1329-1335
86. Severino SK, Yonkers KA (1993) A literature review of psychotic symptoms associated with the premenstruum. Psychosomatics 34:299-306
87. Siegel JP, Meyers B (1986) Comparison of depressed and nondepressed women with severe premenstrual tension syndrome. Psychother Psychosom 45:113-117
88. Silbergeld S, Brast N, Noble EP (1971) The menstrual cycle: a double-blind study of symptoms, mood and behaviour, and biochemical variables using enovid and placebo. Psychosom Med 33:411-428
89. Singer K, Cheng R, Schou M (1974) A controlled evaluation of lithium in the premenstrual tension syndrome. Br J Psychiatry 124:50-51
90. Smith S, Rinehart JS, Ruddock VE, Schiff I (1987) Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trial. Obstet Gynecol 70:37-43
91. Speroff L (1982) The formulation of oral contraceptives: does the amount of estrogen make any clinical difference? Johns Hopkins Med J 150:170-176
92. Steinberg S (1991) The treatment of late luteal phase dysphoric disorder. Life Sci 49:767-802
93. Steiner M, Haskett RF, Osmun JN et al (1980) Premenstrual tension syndrome: the development of research diagnostic criteria and new rating scales. Acta Psychiatr Scand 61:96-102
94. Steiner M, Haskett RF, Carroll BJ et al. (1984) Plasma prolactin and severe premenstrual tension. Psychoneuroendocrinology 9:29-35
95. Steiner M (1992) Female-specific mood disorders. Clin Obstet Gynecol 35:599-611
96. Steiner M, Haskett RF, Carroll BJ et al. (1984) Plasma prolactin and severe PMS. Psychoneuroendocrinology 9 29
97. Steiner M, Steinberg S, Steward D et al. (1995) Fluoxetine in the treatment of premenstrual dysphoria. N Engl J Med 332:1529-1534
98. Stewart DE, Fairman M, Barbadoro S et al. (1994) Follicular and late luteal phase serum fluoxetine levels in women suffering from late luteal phase dysphoric disorder. Biol Psychiatry 36:201-202
99. Stone AB, Pearlstein TB, Brown WA (1991) Fluoxetine in the treatment of late luteal phase dysphoric disorder. J Clin Psychiatry 52:290-293
100. Stout AL, Steege JF, Blazer DG et al (1986) Comparison of lifetime psychiatric diagnosis in premenstrual syndrome clink and community samples. J Nerv Ment Dis 174:517-522
101. Strecker JR (1981) An explorative study into the clinical effects of dydrogesterone in the treatment of premenstrual syndrome. In: Van Keep PA, Utian WH (eds) The premenstrual syndrome MTP, Lancaster, PA, pp 71-79
102. Taylor DL, Matthew RJ, Weinmann ML (1984) Serotonin levels and platelet uptake during pemenstrual tension. Neuropsychobiology 12:16-18
103. Taylor RW (1977) The treatment of prementrual syndrome with dydrogesterone. Curr Med Res Opin 4 [Suppl 4]:35-40
104. Thys-Jacobs S, Ceccareili S, Bierman et al. (1989) Calcium supplementation in premenstrual syndrome: a randomized crossover-trial. J Gen Intern Med 4:183-189
105. Tobin MB, Schmidt PJ, Rubinow TR (1994) Reported alcohol use in women with premenstrual syndrom. Am J Psychiatry 151 1503-1504
106. Tulenheimo A, Laatikanen T, Salminen K (1990) Plasma β-endorphin immunoreactivity in premenstrual tension Br J Obstet Gyneacol 94:26
107. Veeninga AT, Westenberg HG (1992) Serotoninergic function and late luteal phase dysphoric disorder. Psychopharmacology 108:153-158
108. Watson NR, Savas M, Studd JWW et al. (1989) Lancet II:730-732
109. Williams JGC, Martin AJ, Hulkensberg-Tromp (1983) PMS in four european countries: Part II. A double-blind placebo controlled study of dydrogesterone. Br J Sex Med 108-18
110. Williams MJ, Harris RI, Dean BC (1985) Controlled trial of pyridoxine in the premenstrual syndrome. J Int Med Res 13:174-179
111. Yatham LN, Barry S, Dinan TG (1989) Serotonin receptors, buspirone, and premenstrual syndrome. Lancet 1:1447-1448
112. Yatham LN (1993) Is 5HT1A receptor subsensitivty a trait marker for late luteal phase dysphoric disorder? A pilot study. Can J Psychiatry 38:662-664